INVA Q3 2022 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M-31.3% YoY

Gross Profit

$52M77.1% margin

Operating Income

$12M18.3% margin

Net Income

$266M394.8% margin

EPS (Diluted)

$2.80

QoQ Revenue Growth

-37.9%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$16M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$686M

Stockholders' Equity

$641M

Cash & Equivalents

$301M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$98M	-31.3%
Gross Profit	$52M	$98M	-47.0%
Operating Income	$12M	$95M	-87.0%
Net Income	$266M	$72M	+266.6%

Revenue Segments

Product

$5M100%